Lloyd T Lam

Lloyd T Lam

AbbVie Inc - Chicago / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4400155
-
person_outline Lloyd T Lam's MOST POPULAR ARTICLES
1-) ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing plateletsAJ Souers, JD Leverson, ER Boghaert, SL Ackler, ND Catron, J Chen, ...Nature medicine 19 (2), 202-208, 201326162013
2-) Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysG Lenz, GW Wright, NCT Emre, H Kohlhammer, SS Dave, RE Davis, ...Proceedings of the National Academy of Sciences 105 (36), 13520-13525, 200810692008
3-) Molecular diagnosis of Burkitt\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s lymphomaSS Dave, K Fu, GW Wright, LT Lam, P Kluin, EJ Boerma, TC Greiner, ...New England Journal of Medicine 354 (23), 2431-2442, 20069962006
4-) Oncogenic CARD11 mutations in human diffuse large B cell lymphomaG Lenz, RE Davis, VN Ngo, L Lam, TC George, GW Wright, SS Dave, ...Science 319 (5870), 1676-1679, 200810652008
5-) A loss-of-function RNA interference screen for molecular targets in cancerVN Ngo, RE Davis, L Lamy, X Yu, H Zhao, G Lenz, LT Lam, S Dave, ...Nature 441 (7089), 106-110, 20067762006